{"text": ["Was", "The", "Smart", "Money", "Right", "About", "Eli", "Lilly", "and", "Company", "(LLY)?"], "created_at": "2021-05-04 19:39:56"}
{"text": ["Jim", "Cramer:", "Don't", "Bet", "Against", "Comebacks", "in", "This", "Second", "Chance", "Market"], "created_at": "2021-05-04 19:01:00"}
{"text": ["Lilly", "plans", "donation", "of", "COVID-19", "therapies", "to", "Direct", "Relief", "for", "use", "in", "low-", "and", "lower-middle-income", "countries"], "created_at": "2021-05-04 14:07:00"}
{"text": ["AbCellera-Lilly", "Partnered", "Second", "COVID-19", "Antibody", "Enters", "Human", "Trials"], "created_at": "2021-05-04 13:31:26"}
{"text": ["Why", "Lilly's", "Near-Term", "Prospects", "Aren't", "Looking", "That", "Great"], "created_at": "2021-05-04 11:31:00"}
{"text": ["Lilly", "to", "donate", "experimental", "COVID-19", "treatment", "Olumiant", "to", "India"], "created_at": "2021-05-04 11:22:00"}
{"text": ["Lilly", "Outlines", "Robust", "Plans", "to", "Strengthen", "ESG", "Commitments", "Across", "the", "Globe"], "created_at": "2021-05-04 11:00:00"}
{"text": ["Lilly", "accelerating", "baricitinib's", "availability", "in", "India", "following", "receipt", "of", "permission", "for", "restricted", "emergency", "use", "as", "a", "COVID-19", "therapy", "via", "donations", "and", "licensing", "agreements"], "created_at": "2021-05-04 10:42:00"}
{"text": ["New", "Investor?", "Buy", "These", "2", "Rock-Solid", "Stalwarts", "for", "Safety", "and", "Dividends"], "created_at": "2021-05-04 10:20:00"}
